Over 25 companies and 15 academic institutions collaborated together with government agencies to produce a national roadmap on cell therapy manufacturing. The National Cell Manufacturing Consortium (NCMC) is the first U.S. based national consortium focused on developing, maturing, and implementing technologies that can enable large-scale, cost-effective manufacturing of therapeutic cells.
NCMC is established through the Advanced Manufacturing Technologies (AMTech) grant from the National Institute of Standards and Technologies (NIST).


Download the 2017 Roadmap Update


Download the 2016 Roadmap